Morocco orders COVID-19 vaccine as cases approach 100,000

This article was originally published on Nasdaq, on September 18, 2020.

Morocco on Friday signed a deal with Russia’s R-Pharm to buy a COVID-19 vaccine produced under a licence from Britain’s AstraZeneca, the health ministry said, as its total number of cases approached 100,000.

The Ministry did not provide details on the cost and quantity of the order.

AstraZeneca AZN.L licensed R-Pharm in July to produce the vaccine it developed together with Oxford University.

This month, Morocco started taking part in clinical trials of China’s Sinopharm vaccine.

The North African country added a daily record 2,760 cases to its confirmed total on Friday, meaning it has recorded 97,264 in all, including 1,755 deaths.

AstraZeneca has said it is close to having capacity to produce 3 billion doses at sites set up around the world, also sourcing from third-party manufacturers, to supply various governments and organisations. It has a larger order book than any other vaccine developer.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Create a website or blog at WordPress.com

Up ↑

%d bloggers like this: